Lutein prevents high fat diet-induced atherosclerosis in ApoE-deficient mice by inhibiting NADPH oxidase and increasing PPAR expression

Lipids

Volumn 50, Issue 3, 2015, Pages 261-273

  Han, Hao ^a,b   Cui, Wei ^a,b   Wang, Linzhi ^a,b   Xiong, Yufang ^b   Liu, Liegang ^a,b   Sun, Xiufa ^a,b   Hao, Liping ^a,b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Atherosclerosis; Heme oxygenase 1 (HO 1); Low density lipoprotein receptors (LDLr); Lutein; Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase; Peroxisome proliferator activated receptor (PPAR ); Scavenger receptor class B type I (SR BI)

Indexed keywords

ACYL COENZYME A OXIDASE; ACYL COENZYME A OXIDASE 1; APOLIPOPROTEIN E; CARNITINE PALMITOYLTRANSFERASE I; CARNITINE PALMITOYLTRANSFERASE IA; HEME OXYGENASE 1; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SCAVENGER RECEPTOR BI; UNCLASSIFIED DRUG; XANTHOPHYLL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; ENZYME INHIBITION; EXPERIMENTAL ATHEROSCLEROSIS; LIPID DIET; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; ANIMAL; ATHEROSCLEROSIS; BODY WEIGHT; C57BL MOUSE; DRUG EFFECTS; GENE EXPRESSION; GENETICS; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BODY WEIGHT; DIET, HIGH-FAT; GENE EXPRESSION; HEME OXYGENASE-1; LIPID METABOLISM; LUTEIN; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; NADPH OXIDASE; OXIDATIVE STRESS; PPAR ALPHA;

EID: 84925485543     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-015-3992-1     Document Type: Article

References (74)

1. American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2013) Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 129:e28-e292
2. Yang ZJ, Liu J, Ge JP, Chen L, Zhao ZG, Yang WY (2013) Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007-2008 China National Diabetes and Metabolic Disorders Study. Eur Heart 33:213-220
3. Victor VM, Rocha M, Solá E, Bañuls C, Garcia-Malpartida K, Hernández-Mijares A (2009) Oxidative stress, endothelial dysfunction and atherosclerosis. Curr Pharm Des 15:2988-3002
4. Koba S, Hirano T (2011) Dyslipidemia and atherosclerosis. Nihon Rinsho 69:138-143
5. Guzik TJ, Sadowski J, Guzik B, Jopek A, Kapelak B, Przybylowski P, Wierzbicki K, Korbut R, Harrison DG, Channon KM (2006) Coronary artery superoxide production and nox isoform expression in human coronary artery disease. Arterioscler Thromb Vasc Biol 26:333-339
6. Kinkade K, Streeter J, Miller FJ (2013) Inhibition of NADPH oxidase by apocynin attenuates progression of atherosclerosis. Int J Mol Sci. doi: 10.3390/ijms140817017
7. Araujo JA, Zhang M, Yin F (2012) Heme oxygenase-1, oxidation, inflammation, and atherosclerosis. Front Pharmacol. doi: 10.3389/fphar
8. Ishikawa K, Sugawara D, Wang Xp, Suzuki K, Itabe H, Maruyama Y, Lusis AJ (2001) Heme oxygenase-1 inhibits atherosclerotic lesion formation in ldl-receptor knockout mice. Circ Res 88:506-512
9. Wu BJ, Kathir K, Witting PK, Beck K, Choy K, Li C, Croft KD, Mori TA, Tanous D, Adams MR, Lau AK, Stocker R (2006) Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging. J Exp Med 203:1117-1127
10. Taillé C, El-Benna J, Lanone S, Dang MC, Ogier-Denis E, Aubier M, Boczkowski J (2004) Induction of heme oxygenase-1 inhibits NAD(P)H oxidase activity by down-regulating cytochrome b558 expression via the reduction of heme availability. J Biol Chem 279:28681-28688
11. Wierzbicki AS, Viljoen A, Hardman TC, Mikhailidis DP (2013) New therapies to reduce low-density lipoprotein cholesterol. Curr Opin Cardiol 28:452-457
12. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB (1986) Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA 256:2835-2838
13. Musso G, Gambino R, Cassader M (2009) Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res 48:1-26
14. Bonnefont JP, Djouadi F, Prip-Buus C, Gobin S, Munnich A, Bastin J (2004) Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Aspects Med 25:495-520
15. Reddy JK, Mannaerts GP (1994) Peroxisomal lipid metabolism. Annu Rev Nutr 14:343-370
16. Spady DK (1992) Hepatic clearance of plasma low density lipoproteins. Semin Liver Dis 12:373-385
17. Krieger M (2001) Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems. J Clin Invest 108:793-797
18. Khoo HE, Prasad KN, Kong KW, Jiang Y, Ismail A (2011) Carotenoids and their isomers: color pigments in fruits and vegetables. Molecules 16:1710-1738
19. Ribaya-Mercado JD, Blumberg JB (2004) Lutein and zeaxanthin and their potential roles in disease prevention. J Am Coll Nutr 23:S567-S587
20. Sindhu ER, Preethi KC, Kuttan R (2010) Antioxidant activity of carotenoid lutein in vitro and in vivo. Indian J Exp Biol 48:843-848
21. Leung EY, Crozier JE, Talwar D, O'Reilly DS, McKee RF, Horgan PG, McMillan DC (2008) Vitamin antioxidants, lipid peroxidation, tumour stage, the systemic inflammatory response and survival in patients with colorectal cancer. Int J Cancer 123:2460-2464
22. Karppi J, Nurmi T, Kurl S, Rissanen TH, Nyyssönen K (2010) Lycopene, lutein and beta-carotene as determinants of LDL conjugated dienes in serum. Atherosclerosis 209:565-572
23. Lusis AJ (2000) Atherosclerosis. Nature 407:233-241
24. Wang MX, Jiao JH, Li ZY, Liu RR, Shi Q, Ma L (2013) Lutein supplementation healthy nonsmokers. Atherosclerosis 22:380-385
25. Lo HM, Tsai YJ, Du WY, Tsou CJ, Wu WB (2012) A naturally occurring carotenoid, lutein, reduces PDGF and H2O2 signaling and compromised migration in cultured vascular smooth muscle cells. J Biomed Sci. doi: 10.1186/1423-0127-19-18
26. Mai J, Shen X, Shi D, Wei Y, Shen H, Wu M (2010) Effect of lutein on relieving oxidative stress in mice induced by D-galactose. Wei Sheng Yan Jiu 39:430-432
27. Kim JE, Leite JO, DeOgburn R, Smyth JA, Clark RM, Fernandez ML (2011) A lutein-enriched diet prevents cholesterol accumulation and decreases oxidized LDL and inflammatory cytokines in the aorta of guinea pigs. J Nutr 141:1458-1463
28. Xu XR, Zou ZY, Xiao X, Huang YM, Wang X, Lin XM (2011) Effects of lutein supplement on serum inflammatory cytokines, ApoE and lipid profiles in early atherosclerosis population. J Atheroscler Thromb 20:170-177
29. Dwyer JH, Navab M, Dwyer KM, Hassan K, Sun P, Shircore A, Hama-Levy S, Hough G, Wang X, Drake T, Merz CN, Fogelman AM (2001) Oxygenated carotenoid lutein and progression of early atherosclerosis: the Los Angeles atherosclerosis study. Circulation 103:2922-2927
30. Dwyer JH, Paul-Labrador MJ, Fan J, Shircore AM, Merz CN, Dwyer KM (2004) Progression of carotid intima-media thickness and plasma antioxidants: the Los Angeles Atherosclerosis Study. Arterioscler Thromb Vasc Biol 24:313-319
31. Zou Z, Xu X, Huang Y, Xiao X, Ma L, Sun T, Dong P, Wang X, Lin X (2011) High serum level of lutein may be protective against early atherosclerosis: the Beijing atherosclerosis study. Atherosclerosis 219:789-793
32. Xu XR, Zou ZY, Huang YM, Xiao X, Ma L, Lin XM (2012) Serum carotenoids in relation to risk factors for development of atherosclerosis. Clin Biochem 45:1357-1361
33. Karppi J, Kurl S, Ronkainen K, Kauhanen J, Laukkanen JA (2013) Serum carotenoids reduce progression of early atherosclerosis in the carotid artery wall among Eastern Finnish men. PLoS One 8:e64107
34. Daugherty A, Whitman SC (2003) Quantification of atherosclerosis in mice. Methods Mol Biol 209:293-309
35. Sharma P, Chakraborty R, Wang L, Min B, Tremblay ML, Kawahara T, Lambeth JD, Haque SJ (2008) Redox regulation of interleukin-4 signaling. Immunity 29:551-564
36. Araujo JA, Zhang M, Yin F (2012) Heme oxygenase-1, oxidation, inflammation, and atherosclerosis. Front Pharmacol 3:119
37. Zou ZY, Xu XR, Lin XM, Zhang HB, Xiao X, Ouyang L, Huang YM, Wang X, Liu YQ (2014) Effects of lutein and lycopene on carotid intima-media thickness in Chinese subjects with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial. Br J Nutr 111:474-480
38. Bonds DE, Harrington M, Worrall BB, Bertoni AG, Eaton CB, Hsia J, Robinson J, Clemons TE, Fine LJ, Chew EY (2014) Effect of long-chain ω-3 fatty acids and lutein+zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA Intern Med 174:763-771
39. Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. Faseb J 22:659-661
40. Haendeler J, Eckers A, Lukosz M, Unfried K, Altschmied J (2012) Endothelial NADPH oxidase 2: when does it matter in atherosclerosis? Cardiovasc Res 94:1-2
41. Griendling KK, Sorescu D, Ushio-Fukai M (2000) NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86:494-501
42. Mitra S, Deshmukh A, Sachdeva R, Lu J, Mehta JL (2011) Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy. Am J Med Sci 342:135-142
43. Voutilainen S, Nurmi T, Mursu J, Rissanen TH (2006) Carotenoids and cardiovascular health. Am J Clin Nutr 83:1265-1271
44. El-Agamey A, Lowe GM, McGarvey DJ, Mortensen A, Phillip DM, Truscott TG, Young AJ (2004) Carotenoid radical chemistry and antioxidant/pro-oxidant properties. Arch Biochem Biophys 430:37-48
45. Riccioni G, Speranza L, Pesce M, Cusenza S, D'Orazio N, Glade MJ (2012) Novel phytonutrient contributors to antioxidant protection against cardiovascular disease. Nutrition 28:605-610
46. Young AJ, Lowe GM (2001) Antioxidant and prooxidant properties of carotenoids. Arch Biochem Biophys 385:20-27
47. Ciccone MM, Cortese F, Gesualdo M, Carbonara S, Zito A, Ricci G, De Pascalis F, Scicchitano P, Riccioni G (2013) Dietary intake of carotenoids and their antioxidant and anti-inflammatory effects in cardiovascular care. Mediators Inflamm. doi: 10.1155/2013/782137
48. Lo HM, Tsai YJ, Du WY, Tsou CJ, Wu WB (2012) A naturally occurring carotenoid, lutein, reduces PDGF and H2O2 signaling and compromised migration in cultured vascular smooth muscle cells. J Biomed Sci 19:18
49. Kim JE, Clark RM, Park Y, Lee J, Fernandez ML (2012) Lutein decreases oxidative stress and inflammation in liver and eyes of guinea pigs fed a hypercholesterolemic diet. Nutr Res Pract 6:113-119
50. Sheehan AL, Carrell S, Johnson B, Stanic B, Banfi B, Miller FJ Jr (2011) Role for Nox1 NADPH oxidase in atherosclerosis. Atherosclerosis 216:321-326
51. Cave A (2009) Selective targeting of NADPH oxidase for cardiovascular protection. Curr Opin Pharmacol 9:208-213
52. Mizrahi A, Berdichevsky Y, Casey PJ, Pick E (2010) A prenylated p47phox-p67phox-Rac1 chimera is a quintessential NADPH oxidase activator: membrane association and functional capacity. J Biol Chem 285:25485-25499
53. Barry-Lane PA, Patterson C, van der Merwe M, Hu Z, Holland SM, Yeh ET, Runge MS (2001) p47phox is required for atherosclerotic lesion progression in ApoE -/- mice. J Clin Invest 108:1513-1522
54. Kaneto H, Katakami N, Matsuhisa M, Matsuoka TA (2010) Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediators Inflamm. doi: 10.1155/2010/453892
55. Le WD, Xie WJ, Appel SH (1999) Protective role of heme oxygenase-1 in oxidative stress-induced neuronal injury. J Neurosci Res 56:652-658
56. Takahashi T, Morita K, Akagi R, Sassa S (2004) Heme oxygenase-1: a novel therapeutic target in oxidative tissue injuries. Curr Med Chem 11:1545-1561
57. Brydun A, Watari Y, Yamamoto Y, Okuhara K, Teragawa H, Kono F, Chayama K, Oshima T, Ozono R (2007) Reduced expression of heme oxygenase-1 in patients with coronary atherosclerosis. Hypertens Res 30:341-348
58. Wang Y, Ausman LM, Greenberg AS, Russell RM, Wang XD (2010) Dietary lycopene and tomato extract supplementations inhibit nonalcoholic steatohepatitis-promoted hepatocarcinogenesis in rats. Int J Cancer 126:1788-1796
59. McNally SJ, Harrison EM, Ross JA, Garden OJ, Wigmore SJ (2007) Curcumin induces heme oxygenase 1 through generation of reactive oxygen species, p38 activation and phosphatase inhibition. Int J Mol Med 19:165-172
60. Lin HY, Shen SC, Lin CW, Yang LY, Chen YC (2007) Baicalein inhibition of hydrogen peroxide-induced apoptosis via ROS-dependent heme oxygenase 1 gene expression. Biochim Biophys Acta 1773:1073-1086
61. Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB (2008) General and abdominal adiposity and risk of death in Europe. N Engl J Med 359:2105-2120
62. See R, Abdullah SM, McGuire DK, Khera A, Patel MJ, Lindsey JB, Grundy SM, de Lemos JA (2007) The association of differing measures of overweight and obesity with prevalent atherosclerosis: the Dallas heart study. J Am Coll Cardiol 50:752-759
63. Katzmarzyk PT, Heymsfield SB, Bouchard C (2013) Clinical utility of visceral adipose tissue for the identification of cardiometabolic risk in white and African American adults. Am J Clin Nutr 97:480-486
64. Kimmons JE, Blanck HM, Tohill BC, Zhang J, Khan LK (2006) Associations between body mass index and the prevalence of low micronutrient levels among US adults. Med Gen Med 8:59
65. Renzi LM, Hammond BR Jr, Dengler M, Roberts R (2012) The relation between serum lipids and lutein and zeaxanthin in the serum and retina: results from cross-sectional, case-control and case study designs. Lipids Health Dis 29:11-33
66. Schoonjans K, Staels B, Auwerx J (1996) The peroxisome proliferator activated receptors (PPAR) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1302:93-109
67. Li AC, Binder CJ, Gutierrez A, Brown KK, Plotkin CR, Pattison JW, Valledor AF, Davis RA, Willson TM, Witztum JL, Palinski W, Glass CK (2004) Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. J Clin Invest 114:1564-1576
68. Selvaraj RK, Shanmugasundaram R, Klasing KC (2010) Effects of dietary lutein and PUFA on PPAR and RXR isomer expression in chickens during an inflammatory response. Comp Biochem Physiol A Mol Integr Physiol 157:198-203
69. García-Rojas P, Antaramian A, González-Dávalos L, Villarroya F, Shimada A, Varela-Echavarría A, Mora O (2010) Induction of peroxisomal proliferator-activated receptor gamma and peroxisomal proliferator-activated receptor gamma coactivator 1 by unsaturated fatty acids, retinoic acid, and carotenoids in preadipocytes obtained from bovine white adipose tissue. J Anim Sc 88:1801-1808
70. Takayanagi K (2011) Prevention of adiposity by the oral administration of beta-Cryptoxanthin. Front Neurol 2:67
71. Trigatti B, Rayburn H, Viñals M, Braun A, Miettinen H, Penman M, Hertz M, Schrenzel M, Amigo L, Rigotti A, Krieger M (1999) Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc Natl Acad Sci 96:9322-9327
72. Krieger M (1999) Charting the fate of the 'good cholesterol': identification and characterization of the high-density lipoprotein receptor SR-BI. Annu Rev Biochem 68:523-558
73. Braun A, Trigatti BL, Post MJ, Sato K, Simons M, Edelberg JM, Rosenberg RD, Schrenzel M, Krieger M (2002) Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ Res 90:270-276
74. Yang Y, Seo JM, Nguyen A, Pham TX, Park HJ, Park Y, Kim B, Bruno RS, Lee J (2010) Astaxanthin-rich extract from the green alga Haematococcus pluvialis lowers plasma lipid concentrations and enhances antioxidant defense in apolipoprotein E knockout mice. J Nutr 141:1611-1617